Jotbody, a leading provider of nanobody-related services. With a focus on shark and camelids monoclonal nanobody discovery, engineering, and nanobody-based reagents development. Since its establishment in 2020, Jotbody has rapidly expanded its global pool of customers including pharma companies, biotechs, and academic institutions. With our expertise in the field of nanobodies, we offer a full suite of services to support researchers and scientists in their pursuit of innovative solutions in various disciplines. From the discovery phase to the development of high-quality nanobody reagents, we are committed to delivering tailored solutions that meet the specific needs of our clients. Recently Jotbody received the prestigious Forbes 100 Asia to Watch award.